Cadila Pharma Dholka facility successfully passes USFDA audit
The Dholka manufacturing facility passed the USFDA audit with nil 483 observations
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
US FDA audit
Aurobindo Pharma receives Sebi’s warning letter over ongoing US FDA audit
The letter is in regards to certain disclosures made by the company on the ongoing FDA audit of company's Unit-I and observations…
Granules Pharmaceuticals clears US FDA audit
The GPI facility was inspected by the FDA from 24th to 28th January, 2022 for two of its product applications filed
MSN Pharmaceuticals Inc completes its maiden US FDA audit with zero observations
The state-of-the-art finished dosages facility was established to bolster MSN Group’s product portfolio as well as Contract…